Tilray Brands, Inc. (TLRY) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
18/25
Growth 5
Margin 2
Expansion 5
Platform 2
Financial 4
latest quarter score
Earnings Reports
- 18
- 13
- 17
- 14
- 16
- 16